KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) EBT Margin (2016 - 2026)

Quest Diagnostics' EBT Margin history spans 18 years, with the latest figure at 11.54% for Q1 2026.

  • On a quarterly basis, EBT Margin rose 113.0% to 11.54% in Q1 2026 year-over-year; TTM through Mar 2026 was 12.2%, a 54.0% increase, with the full-year FY2025 number at 11.94%, up 4.0% from a year prior.
  • EBT Margin hit 11.54% in Q1 2026 for Quest Diagnostics, down from 11.76% in the prior quarter.
  • Over the last five years, EBT Margin for DGX hit a ceiling of 17.31% in Q1 2022 and a floor of 4.67% in Q4 2022.
  • Historically, EBT Margin has averaged 12.06% across 5 years, with a median of 11.88% in 2023.
  • Biggest five-year swings in EBT Margin: crashed -1887bps in 2022 and later skyrocketed 569bps in 2023.
  • Tracing DGX's EBT Margin over 5 years: stood at 4.67% in 2022, then soared by 122bps to 10.36% in 2023, then grew by 10bps to 11.41% in 2024, then grew by 3bps to 11.76% in 2025, then fell by -2bps to 11.54% in 2026.
  • Business Quant data shows EBT Margin for DGX at 11.54% in Q1 2026, 11.76% in Q4 2025, and 11.65% in Q3 2025.